Ex vivo human lung/immune system model using tissue engineering for studying microbial pathogens with lung tropism

• US 20090227025A1
• Filed: 02/13/2006
• Published: 09/10/2009
• Est. Priority Date: 06/06/2003
• Status: Abandoned Application

• Current Assignee: Board of Regents of the University of Texas System (University of Texas System)
• Original Assignee: Board of Regents of the University of Texas System (University of Texas System)
• Inventors: Mlcak, Ronald P., Niles, Jean A., Cortiella, Joaquin, Nichols, Joan E.
• Application Number:
  US11/352,924
• Publication Number:
  US 20090227025A1
• Time in Patent Office: Days
• US Class Current: 435/395
• CPC Class Codes: A61K 35/42 Respiratory system, e.g. lungs, bronchi or lung cells
• CPC Class Codes: A61K 9/0073 Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy; nasal sprays A61K9/0043; inhalation of vapours of volatile or heated drugs, e.g. essential oils or nicotine, A61K9/007; devices A61M
• CPC Class Codes: A61L 27/3834 Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
• CPC Class Codes: A61L 27/3839 characterised by the site of application in the body materials for artificial blood vessels A61L27/507; materials for use in artificial skin A61L27/60
• CPC Class Codes: A61L 27/3895 using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
• CPC Class Codes: C12N 2501/11 Epidermal growth factor [EGF]
• CPC Class Codes: C12N 2501/115 Basic fibroblast growth factor (bFGF, FGF-2)
• CPC Class Codes: C12N 2501/117 Keratinocyte growth factors (KGF-1, i.e. FGF-7; KGF-2, i.e. FGF-12)
• CPC Class Codes: C12N 2501/119 Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
• CPC Class Codes: C12N 2533/40 Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers
• CPC Class Codes: C12N 5/0689 Stem cells; Progenitors

Abstract

A method for studying scaffold-based tissue engineering approaches in combination with the use of progenitor or stem cells to generate new lung tissue in an in vitro system. The engineered tissue system of this invention is used to monitor lung and immune system exposure of pathogen and/or toxins. The method involves growing engineered lung/immune tissue from progenitor cells in a bioreactor and then exposing the engineered lung/immune tissue to a pathogen and/or toxin. Once exposed, response of the engineered tissue is monitored to determine the effects of exposure to the immune component of the tissue and to lung component of the tissue. This invention also involves development of mixed engineered tissues including a first fully functional engineered tissue such as lung tissue and a second fully functional engineered tissued such as immune tissue from a single animal donor. The mixed systems can include more than two engineered tissues.

Claims

1. :

An engineered tissue system comprising of at least one tissue selected from the group consisting of lung tissue, lymphocytes or combinations thereof and at least one mixed engineered tissue comprising at least two individual engineered tissues, where said engineered tissues are generated on a scaffold in a bio-reactor under microgravity conditions sufficient to allow 3D orientation and structural differentiation.

2. :

The system of claim 1, wherein the individual tissues are from a single donor.

3. :

The system of claim 1, wherein the engineered tissues comprise organoids and/or nodes.

4. :

The system of claim 1, wherein the individual tissues are selected from the group consisting of (19) Keratinizing epithelial cells such as Epidermal keratinocyte (differentiating epidermal cell), Epidermal basal cell (stem cell), Keratinocyte of fingernails and toenails, Nail bed basal cell (stem cell), Medullary hair shaft cell, Cortical hair shaft cell, Cuticular hair shaft cell, Cuticular hair root sheath cell, Hair root sheath cell of Huxley'"'"'s layer, Hair root sheath cell of Henle'"'"'s layer, External hair root sheath cell, and Hair matrix cell (stem cell);

(20) Wet stratified barrier epithelial cells such as, Surface epithelial cell of stratified squamous epithelium of cornea, tongue, oral cavity, esophagus, anal canal, distal urethra and vagina, basal cell (stem cell) of epithelia of cornea, tongue, oral cavity, esophagus, anal canal, distal urethra and vagina, and Urinary epithelium cell (lining urinary bladder and urinary ducts);

(21) Exocrine secretory epithelial cells such as, Salivary gland mucous cell (polysaccharide-rich secretion), Salivary gland serous cell (glycoprotein enzyme-rich secretion), Von Ebner'"'"'s gland cell in tongue (washes, taste buds), Mammary gland cell (milk secretion), Lacrimal gland cell (tear secretion), Ceruminous gland cell in ear (wax secretion), Eccrine sweat gland dark cell (glycoprotein secretion), Eccrine sweat gland clear cell (small molecule secretion), Apocrine sweat gland cell (odoriferous secretion, sex-hormone sensitive), Gland of Moll cell in eyelid (specialized sweat gland), Sebaceous gland cell (lipid-rich sebum secretion), Bowman'"'"'s gland cell in nose (washes olfactory epithelium), Brunner'"'"'s gland cell in duodenum (enzymes and alkaline mucus), Seminal vesicle cell (secretes seminal fluid components, including fructose for swimming sperm), Prostate gland cell (secretes seminal fluid components), Bulbourethral gland cell (mucus secretion), Bartholin'"'"'s gland cell (vaginal lubricant secretion), Gland of Littre cell (mucus secretion), Uterus endometrium cell (carbohydrate secretion), Isolated goblet cell of respiratory and digestive tracts (mucus secretion), Stomach lining mucous cell (mucus secretion), Gastric gland zymogenic cell (pepsinogen secretion), Gastric gland oxyntic cell (hydrochloric acid secretion), Pancreatic acinar cell (bicarbonate and digestive enzyme secretion), Paneth cell of small intestine (lysozyme secretion), Type II pneumocyte of lung (surfactant secretion), and Clara cell of lung;

(22) Hormone secreting cells such as, Anterior pituitary cells (Somatotropes, Lactotropes, Thyrotropes, Gonadotropes, Corticotropes), Intermediate pituitary cell—

secreting melanocyte-stimulating hormone, Magnocellular neurosecretory cells (secreting oxytocin, secreting vasopressin), Gut and respiratory tract cells secreting serotonin (secreting endorphin, secreting somatostatin, secreting gastrin, secreting secretin, secreting cholecystokinin, secreting insulin, secreting glucagon, secreting bombesin), Thyroid gland cells (thyroid epithelial cell, parafollicular cell), Parathyroid gland cells (Parathyroid chief cell, oxyphil cell), Adrenal gland cells (chromaffin cells, secreting steroid hormones (mineralcorticoids and gluco corticoids), Leydig cell of testes secreting testosterone, Theca interna cell of ovarian follicle secreting estrogen, Corpus luteum cell of ruptured ovarian follicle secreting progesterone, Kidney juxtaglomerular apparatus cell (renin secretion), Macula densa cell of kidney, Peripolar cell of kidney, and Mesangial cell of kidney;

(23) (Gut, Exocrine Glands and Urogenital Tract) such as intestinal brush border cell (with microvilli), Exocrine gland striated duct cell, Gall bladder epithelial cell, Kidney proximal tubule brush border cell, Kidney distal tubule cell, Ductulus efferens nonciliated cell, Epididymal principal cell, and Epididymal basal cell;

(24) Metabolism and storage cells such as Hepatocyte (liver cell), White fat cell, Brown fat cell, Liver lipocyte;

(25) Barrier function cells (Lung, Gut, Exocrine Glands and Urogenital Tract) such as Type I pneumocyte (lining air space of lung), Pancreatic duct cell (centroacinar cell). Nonstriated duct cell (of sweat gland, salivary gland, mammary gland, etc.), Kidney glomerulus parietal cell, Kidney glomerulus podocyte, Loop of Henle thin segment cell (in kidney), Kidney collecting duct cell, Duct cell (of seminal vesicle, prostate gland, etc.);

(26) Epithelial cells lining closed internal body cavities such as Blood vessel and lymphatic vascular endothelial fenestrated cell, Blood vessel and lymphatic vascular endothelial continuous cell, Blood vessel and lymphatic vascular endothelial splenic cell, Synovial cell (lining joint cavities, hyaluronic acid secretion), Serosal cell (lining peritoneal, pleural, and pericardial cavities), Squamous cell (lining perilymphatic space of ear), Squamous cell (lining endolymphatic space of ear), Columnar cell of endolymphatic sac with microvilli (lining endolymphatic space of ear), Columnar cell of endolymphatic sac without microvilli (lining endolymphatic space of ear), Dark cell (lining endolymphatic space of ear), Vestibular membrane cell (lining endolymphatic space of ear), Stria vascularis basal cell (lining endolymphatic space of ear), Stria vascularis marginal cell (lining endolymphatic space of ear). Cell of Claudius (lining endolymphatic space of ear), Cell of Boettcher (lining endolymphatic space of ear), Choroid plexus cell (cerebrospinal fluid secretion), Pia-arachnoid squamous cell. Pigmented ciliary epithelium cell of eye, Nonpigmented ciliary epithelium cell of eye, and Corneal endothelial cell;

(27) Ciliated cells with propulsive function such as Respiratory tract ciliated cell, Oviduct ciliated cell (in female), Uterine endometrial ciliated cell (in female), Rete testis cilated cell (in male), Ductulus efferens ciliated cell (in male), and Ciliated ependymal cell of central nervous system (lining brain cavities);

(28) Extracellular matrix secretion cells such as Ameloblast epithelial cell (tooth enamel secretion), Planum semilunatum epithelial cell of vestibular apparatus of ear (proteoglycan secretion), Organ of Corti interdental epithelial cell (secreting tectorial membrane covering hair cells), Loose connective tissue fibroblasts, Corneal fibroblasts, Tendon fibroblasts, Bone marrow reticular tissue fibroblasts, Other nonepithelial fibroblasts, Pericyte, Nucleus pulposus cell of intervertebral disc, Cementoblast/cementocyte (tooth root bonelike cementum secretion), Odontoblast/odontocyte (tooth dentin secretion), Hyaline cartilage chondrocyte, Fibrocartilage chondrocyte, Elastic cartilage chondrocyte, Osteoblast/osteocyte, Osteoprogenitor cell (stem cell of osteoblasts), Hyalocyte of vitreous body of eye, and Stellate cell of perilymphatic space of ear;

(29) Contractile cells such as Red skeletal muscle cell (slow), White skeletal muscle cell (fast), Intermediate skeletal muscle cell, nuclear bag cell of Muscle spindle, nuclear chain cell of Muscle spindle, Satellite cell (stem cell), Ordinary heart muscle cell, Nodal heart muscle cell, Purkinje fiber cell, Smooth muscle cell (various types), Myoepithelial cell of iris, Myoepithelial cell of exocrine glands, and Red Blood Cell;

(30) Blood and immune system cells such as Erythrocyte (red blood cell), Megakaryocyte (platelet precursor), Monocyte, Connective tissue macrophage (various types), Epidermal Langerhans cell, Osteoclast (in bone), Dendritic cell (in lymphoid tissues), Microglial cell (in central nervous system), Neutrophil granulocyte, Eosinophil granulocyte, Basophil granulocyte, Mast cell, Helper T cell, Suppressor T cell, Cytotoxic T cell, B cells, Natural killer cell, Reticulocyte, and Stem cells and committed progenitors for the blood and immune system (various types);

(31) Sensory transducer cells such as Auditory inner hair cell of organ of Corti, Auditory outer hair cell of organ of Corti, Basal cell of olfactory epithelium (stem cell for olfactory neurons), Cold-sensitive primary sensory neurons, Heat-sensitive primary sensory neurons, Merkel cell of epidermis (touch sensor), Olfactory receptor neuron, Pain-sensitive primary sensory neurons (various types), Photoreceptor rod cell of eye, Photoreceptor blue-sensitive cone cell of eye, Photoreceptor green-sensitive cone cell of eye, Photoreceptor red-sensitive cone cell of eye, Proprioceptive primary sensory neurons (various types), Touch-sensitive primary sensory neurons (various types), Type I carotid body cell (blood pH sensor), Type II carotid body cell (blood pH sensor), Type I hair cell of vestibular apparatus of ear (acceleration and gravity), Type II hair cell of vestibular apparatus of ear (acceleration and gravity), and Type I taste bud cell;

(32) Autonomic neuron cells such as Cholinergic neural cell (various types), Adrenergic neural cell (various types), Peptidergic neural cell (various types);

(33) Sense organ and peripheral neuron supporting cells such as Inner pillar cell of organ of Corti. Outer pillar cell of organ of Corti, Inner phalangeal cell of organ of Corti, Outer phalangeal cell of organ of Corti, Border cell of organ of Corti, Hensen cell of organ of Corti, Vestibular apparatus supporting cell, Type I taste bud supporting cell, Olfactory epithelium supporting cell, Schwann cell, Satellite cell (encapsulating peripheral nerve cell bodies), and Enteric glial cell;

(34) Central nervous system neurons and glial cells such as Astrocyte (various types), Neuron cells (large variety of types, still poorly classified), Oligodendrocyte, and Spindle neuron;

(35) Lens cells such as Anterior lens epithelial cell, and Crystallin-containing lens fiber cell;

(36) Pigment cells such as Melanocyte, and Retinal pigmented epithelial cell;

(37) Germ cells such as Oogonium/Oocyte, Spermatid, Spermatocyte, Spermatogonium cell (stem cell for spermatocyte), and Spermatozoon; and

Nurse cells such as Ovarian follicle cell, Sertoli cell (in testis), and Thymus epithelial cell, or mixtures of combinations thereof.

6. :

The system of claim 1, wherein the individual engineered tissues are selected from the groups consisting of lung tissue, lymphocytes or combinations thereof.

5. (canceled)

7. :

A method for studying tissue responses comprising the steps of;

isolating stem cells from an animal, differentiating and growing the isolated stem cells on a scaffold in a bio-reactor under microgravity conditions sufficient to allow 3D orientation and structural differentiation to form stable, fully functional individual engineered tissues,

constructing a mixed engineered tissue from two or more of the individual engineered tissues,

exposing the mixed engineered tissue and its constituent individual engineered tissues to a pathogen, a toxin and/or an environmental stress, and

monitoring the response of each tissue to the pathogen, toxin and/or environmental stress.

8. :

The method of claim 7, further comprising the step of;

intermittently, periodically or continuously exposing the tissues to the pathogen, toxin and/or environmental stress and

monitoring the tissues to determine longer term tissue responses.

9. :

A method for studying tissue responses comprising the steps of;

isolating stem cells from an animal, differentiating and growing the isolated stem cells on a scaffold in a bio-reactor under microgravity conditions sufficient to allow 3D orientation and structural differentiation to form stable, fully functional individual engineered tissues,

constructing a mixed engineered tissue from two or more of the individual engineered tissues,

exposing the mixed engineered tissue and its constituent individual engineered tissues to a pathogen and

monitoring the response of each tissue to the pathogen.

10. :

The method of claim 9, further comprising the steps of;

intermittently, periodically or continuously exposing the tissues to the pathogen, and monitoring the tissues to determine disease propagation and progression.

11. :

A method for studying a treatment comprising the steps of;

isolating stem cells from an animal, differentiating and growing the isolated stem cells on a scaffold in a bio-reactor under microgravity conditions sufficient tot allow 3D orientation and structural differentiation to form stable, fully functional individual engineered tissues,

constructing a mixed engineered tissue from two or more of the individual engineered tissues,

exposing the mixed engineered tissue and its constituent individual engineered tissues to a pathogen, a toxin and/or an environmental stress to form infected tissues, monitoring the response of each infected tissue to the pathogen, toxin and/or environmental stress,

exposing the infected tissues to a treatment, and

monitoring the response of the tissues to the treatment.

12. :

The method of claim 11, further comprising the steps of;

intermittently, periodically or continuously exposing the tissues to the treatment, and

monitoring the treated tissues to determine longer term treated tissue responses.

13. :

A method for monitoring treatments against toxins, infections, dysfunctions or diseases, where the method includes the steps of;

inducing a toxic response, infection, dysfunction and/or a disease in a engineered tissue comprising a plurality of individual engineered tissues and one or more mixed engineered tissue including two or more individual engineered tissues, where the tissues are generated on a scaffold in a bio-reactor under microgravity conditions sufficient to allow 3D orientation and structural differentiation,

administering a treatment under treating conditions and

monitoring a response of the model to the treatment,

where the treating conditions include treatment concentration, if the treatment is a pharmaceutical, treatment intensity, if the treatment is not a pharmaceutical, exposure time, medium properties or other factors that impact pathogenicity and/or toxicity.

14. :

An in vitro grown, engineered lung tissue comprising engineered lung tissues derived from lung resident stem or progenitor cells, which normally function in repair and homeostasis of the lung, generated on a scaffold in a bio-reactor under microgravity conditions sufficient to allow 3D orientation and structural differentiation, where the engineered tissue is are capable of being utilized an as in vitro engineered mammalian including human lung model for examining pathogensis of pathogen.

15. :

An ex vivo engineering lung tissue comprising immature lung cells isolated adult human stem cells from peripheral blood and grown in a rotary cell culture system that maintains the cells in a 3D orientation, where the cells are capable of differentiation into mature, fully functional lung tissue.

16. :

The tissue of claim 15, wherein the tissue comprises mature, fully functional engineered lung tissue.

17. :

The tissue of claim 15, wherein the tissue comprises artificial lung tissue organoid.

18. :

An implantable ex vivo grown, mature, fully lung cells, tissues or organoids comprising engineered lung tissues derived from lung resident stem or progenitor cells, which normally function in repair and homeostasis of the lung, generated on a scaffold in a bio-reactor under microgravity conditions sufficient to allow 3D orientation and structural differentiation.

19. :

A cell population comprising somatic lung progenitor cells capable of support lung tissue development in both in vitro and in vivo models, where the cells can be differentiated into numerous cell types that produce Clara cell protein 10 (CC10), cytokeratin, and surfactant protein C(SP-C) prior to formation of cell/polymer constructs. The present invention also provides long-term (4-8 week) in vitro stable cultures of tissue engineered lung epithelium as human lung models for pathogenesis studies using influenza A virus and/or other pathogens and/or toxins.

20. :

An engineered tissue for producing anti-microbial peptides called defensins and cathelicidins, which are innate immune factors present in airway surface liquid and make up part of the lung'"'"'s natural defenses comprising somatic lung progenitor cells generated on a scaffold in a bio-reactor under microgravity conditions sufficient to allow 3D orientation and structural differentiation to form several different cell types in the lung and respiratory tract including airway epithelial cells, macrophages and neutrophils which produce prostaglandins, cyclooxygenase and lipoxygenase products and de novo metabolism of arachidonic acid to both cyclooxygenase and lipoxygenase products and the production of leukotrienes is dependent on both time in culture and agonist.